SCHEMBL1989963

SCHEMBL1989963

CC(C)(O)CN1CCC(n2nc(C3=C(c4c[nH]c5sccc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 13/20 0.38
PRKCA P17252 13/20 0.38
PRKCG P05129 12/20 0.38
PRKCE Q02156 11/20 0.38
PRKCD Q05655 11/20 0.38
CAMK2D Q13557 10/20 0.38
PRKCH P24723 10/20 0.38
CAMK2B Q13554 7/20 0.38
CAMK2G Q13555 7/20 0.38
CAMK2A Q9UQM7 7/20 0.38
PRKCZ Q05513 6/20 0.38
SRC P12931 3/20 0.38
HTR4 Q13639 2/20 0.37
GSK3B P49841 6/20 0.35
PRKCQ Q04759 3/20 0.35
PDGFRB P09619 2/20 0.35
PIM1 P11309 2/20 0.35
RPS6KB1 P23443 2/20 0.35
CDK2 P24941 2/20 0.35
AXL P30530 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2001228 0.91 PRKCB (0.37) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1996716 0.91 CAMK2D (0.39) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1994738 0.88 PRKCA (0.40) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1991764 0.87 CAMK2D (0.44) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1990972 0.87 PRKCB (0.51) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1999066 0.86 PRKCG (0.43) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1997672 0.86 PRKACA (0.43) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1993324 0.86 CAMK2D (0.39) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1989564 0.85 PRKCB (0.56) PRKCBPRKCAPRKCGPRKCEPRKCD
SCHEMBL1991096 0.85 PRKCA (0.39) PRKCBPRKCAPRKCGPRKCEPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCB 3335/4885PRKCA 3438/4885PRKCG 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.